Kaposi Sarcoma Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

Pages: 150 Published: March 29, 2022 Report Code: GDHC6858CTIDB

The Kaposi Sarcoma Clinical Trial market research report provides an overview of the Kaposi Sarcoma clinical trials scenario. This report provides top-line data relating to the clinical trials on Kaposi Sarcoma. The report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report also offers coverage of disease clinical trials by region, country, phase, trial status, end points status, and sponsor type. The report also provides prominent drugs for in-progress trials.

Regional and Country-Wise Outlook of the Kaposi Sarcoma Clinical Trials Market

The Kaposi Sarcoma clinical trials market is the largest in North America, followed by Asia Pacific, Europe, the Middle East and Africa, and South and Central America.

In a country-wise analysis, as of March 2022, the US has the highest number of Kaposi Sarcoma clinical trials, followed by China, the UK, France, Italy, Uganda, Australia, Belgium, Brazil, and Germany. Germany has the highest average patient enrollment in Kaposi Sarcoma clinical trials. 

G7 countries: Among the G7 (the US, the UK, Japan, Germany, France, Canada, and Italy) countries, the US has the highest proportion of Kaposi Sarcoma to Infectious Disease clinical trials. Moreover, out of all the clinical trials conducted in the G7 countries, the majority were in the US.

E7 countries: Among the E7 (Brazil, Russia, India, China, Mexico, Turkey, and Indonesia) countries, Brazil has the highest proportion of Kaposi Sarcoma to Infectious Disease clinical trials. Out of all the clinical trials conducted in the E7 countries, the majority were in China.

Kaposi Sarcoma Clinical Trials Analysis, By Regions

Kaposi Sarcoma Clinical Trials Analysis, By Regions

For more regional insights, download a free report sample

Key Sponsor Types in the Kaposi Sarcoma Clinical Trials Market

The key sponsor types in the Kaposi Sarcoma clinical trials market are institution, company, and government. Out of them, institution dominates the market.

Kaposi Sarcoma Clinical Trials Market, by Sponsor Types

Kaposi Sarcoma Clinical Trials Market, by Sponsor Types

For more sponsor type insights, download a free report sample

Key Companies in the Kaposi Sarcoma Clinical Trials Market

The key companies in the Kaposi Sarcoma clinical trials market are Emmes Co LLC, Bristol-Myers Squibb Co, Pfizer Inc, Ligand Pharmaceuticals Inc, Sequus Pharmaceuticals Inc (Inactive), AstraZeneca Plc, Thermo Fisher Scientific Inc, PTC Therapeutics Inc, Merck & Co Inc, and F. Hoffmann-La Roche Ltd.

Kaposi Sarcoma Clinical Trials Market, by Companies

Kaposi Sarcoma Clinical Trials Market, by Companies

To know more about the companies, download a free report sample

Kaposi Sarcoma Clinical Trials Market Report Overview

Key Regions Asia-Pacific, Europe, Northern America, Middle East and Africa, and South and Central America
Key Countries The US, China, the UK, France, Italy, Uganda, Australia, Belgium, Brazil, and Germany
Key Sponsor Types Institution, Company, and Government
Key Companies Emmes Co LLC, Bristol-Myers Squibb Co, Pfizer Inc, Ligand Pharmaceuticals Inc, Sequus Pharmaceuticals Inc (Inactive), AstraZeneca Plc, Thermo Fisher Scientific Inc, PTC Therapeutics Inc, Merck & Co Inc, and F. Hoffmann-La Roche Ltd

Scope

The report provides:

  • A snapshot of the global clinical trials landscape
  • Top level data related to the clinical trials by region, country, trial status, trial phase, sponsor type, and end point status
  • Reviews of top companies involved and enlists all trials pertaining to the company
  • All the unaccomplished trials with the reason for unaccomplishment
  • Enrollment trends for the past five years
  • Latest news for the past three months

Reasons to Buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top-level analysis of global clinical trials market which helps in identifying key business opportunities
  • Supports understanding of trial count and enrollment trends by country in the global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted trials
  • Facilitates clinical trial assessment of the indication on a global, regional, and country level

Table of Contents

Table of Contents

List of Tables

List of Figures

Report Guidance

GlobalData Clinical Trials Report Coverage

Clinical Trials by Region

Clinical Trials and Average Enrollment by Country

Clinical Trials by G7 Countries: Proportion of Kaposi Sarcoma to Infectious Disease Clinical Trials

Clinical Trials by Phase in G7 Countries

Clinical Trials in G7 Countries by Trial Status

Clinical Trials by E7 Countries: Proportion of Kaposi Sarcoma to Infectious Disease Clinical Trials

Clinical Trials by Phase in E7 Countries

Clinical Trials in E7 Countries by Trial Status

Clinical Trials by Phase

In Progress Trials by Phase

Clinical Trials by Trial Status

Clinical Trials by End Point Status

Subjects Recruited Over a Period of Time

Clinical Trials by Sponsor Type

Prominent Sponsors

Top Companies Participating in Kaposi Sarcoma Therapeutics Clinical Trials

Prominent Drugs

Clinical Trial Profile Snapshots

Appendix

Abbreviations

Definitions

Research Methodology

Secondary Research

About GlobalData

Contact Us

Source

List of Tables

List of Tables

Kaposi Sarcoma Therapeutics, Global, Clinical Trials by Region, 2022*

Kaposi Sarcoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2022*

Kaposi Sarcoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2022*

Kaposi Sarcoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2022*

Kaposi Sarcoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2022*

Kaposi Sarcoma Therapeutics Clinical Trials, North America, Top Countries, 2022*

Kaposi Sarcoma Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2022*

Kaposi Sarcoma Therapeutics Clinical Trials, Central and South America, Top Countries, 2022*

Proportion of Kaposi Sarcoma to Infectious Disease Clinical Trials, G7 Countries (%), 2022*

Kaposi Sarcoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2022*

Kaposi Sarcoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2022*

Proportion of Kaposi Sarcoma to Infectious Disease Clinical Trials, E7 Countries (%), 2022*

Kaposi Sarcoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2022*

Kaposi Sarcoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2022*

Kaposi Sarcoma Therapeutics, Global, Clinical Trials by Phase, 2022*

Kaposi Sarcoma Therapeutics, Global, Clinical Trials In Progress by Phase 2022*

Kaposi Sarcoma Therapeutics, Global, Clinical Trials by Trial Status, 2022*

Kaposi Sarcoma Therapeutics Clinical Trials, Global, by End Point Status, 2022*

Kaposi Sarcoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2017-2021

Kaposi Sarcoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2022*

Kaposi Sarcoma Therapeutics Clinical Trials, Global, Key Sponsors, 2022*

Kaposi Sarcoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2022*

Kaposi Sarcoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2022*

List of Figures

List of Figures

Kaposi Sarcoma Therapeutics, Global, Clinical Trials by Region (%), 2022*

Kaposi Sarcoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2022*

Kaposi Sarcoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2022*

Kaposi Sarcoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2022*

Kaposi Sarcoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2022*

Kaposi Sarcoma Therapeutics Clinical Trials, North America, Top Countries (%), 2022*

Kaposi Sarcoma Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2022*

Kaposi Sarcoma Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2022*

Proportion of Kaposi Sarcoma to Infectious Disease Clinical Trials, G7 Countries (%), 2022*

Kaposi Sarcoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2022*

Kaposi Sarcoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2022*

Proportion of Kaposi Sarcoma to Infectious Disease Clinical Trials, E7 Countries (%), 2022*

Kaposi Sarcoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2022*

Kaposi Sarcoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2022*

Kaposi Sarcoma Therapeutics, Global, Clinical Trials by Phase (%), 2022*

Kaposi Sarcoma Therapeutics, Global, Clinical Trials In Progress by Phase, 2022*

Kaposi Sarcoma Therapeutics, Global, Clinical Trials by Trial Status, 2022*

Kaposi Sarcoma Therapeutics Clinical Trials, Global, by End Point Status, 2022*

Kaposi Sarcoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2017-2021

Kaposi Sarcoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2022*

Kaposi Sarcoma Therapeutics Clinical Trials, Global, Key Sponsors, 2022*

Kaposi Sarcoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2022*

Kaposi Sarcoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2022*

GlobalData Methodology

Frequently Asked Questions

The key regions in the Kaposi Sarcoma clinical trials market are Asia-Pacific, Europe, North America, Middle East and Africa, and South and Central America.

The key countries in the Kaposi Sarcoma clinical trials market are the US, China, the UK, France, Italy, Uganda, Australia, Belgium, Brazil and Germany.

The key sponsor types in the Kaposi Sarcoma clinical trials market are institution, company, and government.

The key companies in the Kaposi Sarcoma clinical trials market are Emmes Co LLC, Bristol-Myers Squibb Co, Pfizer Inc, Ligand Pharmaceuticals Inc, Sequus Pharmaceuticals Inc (Inactive), AstraZeneca Plc, Thermo Fisher Scientific Inc, PTC Therapeutics Inc, Merck & Co Inc, and F. Hoffmann-La Roche Ltd.

$2,500

Can be used by individual purchaser only

$7,500

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Get in touch to find out about our multi-purchase discounts

reportstore@globaldata.com
Tel +44 (0) 20 7947 2960

Every customer’s requirement is unique. We understand that and can customize the report basis your exact research requirements pertaining to market insights, innovation insights, strategy and planning, and competitive intelligence. You can also avail the option of purchasing stand-alone sections of the report or request for a country specific report.

GDPR + CCPA Compliant

Personal and transaction information are kept safe from unauthorised use.

Recently Viewed Reports

Testimonial

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods
Looking to stay on top of industry & market trends?

Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.